Acro Biomedical (ACBM) Cash from Financing (Quarterly): 0.0103M

Acro Biomedical Co. Ltd. (ACBM)

0.026 0.00 (0.00%) USD | OTCM | Oct 05, 16:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2016. Start Trial.

Date	Value
June 30, 2026	0.0103M
March 31, 2026	0.0496M
December 31, 2025	0.0252M
September 30, 2025	0.0587M
June 30, 2025	0.0938M
March 31, 2025	0.0223M
December 31, 2024	0.0103M
September 30, 2024	0.0061M
June 30, 2024	0.0071M
March 31, 2024	0.0133M
December 31, 2023	0.0097M
September 30, 2023	0.0001M
June 30, 2023	0.0001M
March 31, 2023	0.00
December 31, 2022	0.0002M
September 30, 2022	0.0573M
June 30, 2022	0.0002M
March 31, 2022	0.0003M
December 31, 2021	0.0011M

Date	Value
September 30, 2021	0.0037M
June 30, 2021	-0.2416M
March 31, 2021	0.0146M
December 31, 2020	0.055M
September 30, 2020	0.0644M
June 30, 2020	0.0616M
March 31, 2020	0.0357M
December 31, 2019	0.0439M
September 30, 2019	-0.0416M
June 30, 2019	0.085M
March 31, 2019	-0.1227M
September 30, 2018	0.0007M
June 30, 2018	0.0451M
March 31, 2018	0.0589M
December 31, 2017	0.00
September 30, 2017	0.453M
June 30, 2017	0.0176M
March 31, 2017	0.0271M
December 31, 2016	0.00

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks